Profile of infections in Polish pediatric hematology, oncology and stem cell transplantation centers in 2014-2015
暂无分享,去创建一个
J. Wachowiak | W. Młynarski | N. Irga-Jaworska | T. Szczepański | M. Bartnik | W. Badowska | M. Matysiak | J. Kowalczyk | J. Styczyński | E. Gospodarek-Komkowska | W. Balwierz | B. Dembowska-Baginska | M. Wysocki | T. Ociepa | M. Salamonowicz | J. Gozdzik | A. Chybicka | E. Drożyńska | A. Szmydki-Baran | K. Semczuk | K. Dzierżanowska-Fangrat | O. Zając‐Spychała | M. Krawczuk-Rybak | A. Zaucha-Prażmo | K. Czyżewski | Ł. Hutnik | G. Sobol-Milejska | P. Zalas‐Więcek | O. Gryniewicz-Kwiatkowska | F. Pierlejewski | L. Chełmecka-Wiktorczyk | E. Gorczyńska | R. Tomaszewska | G. Karolczyk | M. Woszczyk | K. Kałwak | M. Plonowski | M. Dziedzic | J. Klepacka | W. Stolpa | J. Fraczkiewicz | A. Czajńska-Deptuła | E. Bień | Elwira Kulicka | P. Wawryków | Z. Gamrot-Pyka | Z. Małas | A. Urbanek-Dądela | P. Zalas-Więcek | P. Wawrykow
[1] M. Boeckh,et al. How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation. , 2016, Blood.
[2] J. Wachowiak,et al. Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide study. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[3] E. Roilides,et al. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. , 2014, The Lancet. Oncology.
[4] D. Livermore,et al. The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients , 2013, Haematologica.
[5] D. Livermore,et al. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011) , 2013, Haematologica.
[6] D. Livermore,et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia , 2013, Haematologica.
[7] J. Donnelly,et al. The end of the road for empirical antifungal treatment? , 2013, The Lancet. Infectious diseases.
[8] J. Donnelly,et al. The role of antifungal treatment in hematology , 2012, Haematologica.
[9] M. Aricò,et al. Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation , 2010, Haematologica.
[10] H. Einsele,et al. Viral disease prevention after hematopoietic cell transplantation , 2009, Bone Marrow Transplantation.
[11] C. Viscoli,et al. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[12] J. Styczyński,et al. Prevention of infectious complications in pediatric HSCT , 2008, Bone Marrow Transplantation.
[13] H. Einsele,et al. Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT , 2008, Bone Marrow Transplantation.
[14] J. Styczyński,et al. Infectious Complication in 314 Patients after High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation: Risk Factors Analysis and Outcome , 2007, Infection.